In part one of our 20th anniversary special, hear from Visiopharm CEO Michael Grunkin. Visiopharm offers image analysis software for pathology images that has evolved over 20 years, adapting to digital microscopy and digital pathology advancements. AI capabilities in computer vision have taken tissue image analysis to a new level. Interoperability and data visualization advancements are also driving progress in digital pathology. Join the episode to learn more about the 20-year journey of digital microscopy and pathology with Visiopharm’s CEO.

• Let us know what you think of the episode and any topics you would like us to cover in the future by sending us an email at: podcasts@visiopharm.com

Machine learning has revolutionized pathology in recent years. With an abundance of pathology data and relevant applications, AI has exploded in the field. The success of deep learning in the CAMELYON challenge, increased accessibility of whole slide scanning and open-source deep learning frameworks have contributed to its growth. In this episode, Dr Aleksandra Zuraw interviews Visiopharm’s Jeppe Thagaard about AI’s takeover of the image analysis field and the future of classical image analysis methods. Thagaard shares his personal journey in digital pathology and the advancements in AI image analysis.

• Let us know what you think of the episode and any topics you would like us to cover in the future by sending us an email at: podcasts@visiopharm.com

In our second anniversary special, hear from Visiopharm CEO and founder Michael Grunkin. Digital pathology, with regulatory approvals for whole slide imaging, aims to increase precision & productivity in pathology labs. However, slow adoption is due to high investment costs beyond just the scanner. Image analysis and AI hold higher value for pathology, but standardization of tissue diagnostic assays is still lacking. Only fully digital pathology institutions benefit, but incremental adoption could increase adoption & value for all. Learn more in the episode and from Visiopharm’s contributions to digital transformation in pathology.

• Let us know what you think of the episode and any topics you would like us to cover in the future by sending us an email at: podcasts@visiopharm.com

Data extraction from virtual slides is the foundation for the identification of novel patterns that are difficult or impossible to quantify by the human eye. Along with innovative technologies like high plex immunofluorescence, artificial intelligence allows the caption of deeper insights, contextual information, and describes spatial relationships.

Presented at the virtual Pathology Visions 2020 meeting during Visiopharm’s Industry Workshop on Monday, October 26, 2020.

Prof Ralf Huss, University Hospital Augsburg

Ralf Huss is a Professor of Pathology and the Managing Deputy Director of Pathology and Molecular Diagnostics at the University Hospital in Augsburg, Germany. He also heads the Center for Digital Medicine. He is certified in anatomical, experimental, and molecular pathology, with over 30 years of experience in histopathology, immunology, cancer research, and oncology.

Is your digital pathology implementation holding you back from realizing the full potential of your data?

Join this short, moderated discussion to learn how to overcome 5 common challenges life sciences organizations experience as they scale their digital pathology operations. These challenges range from data standardization to collaboration, and our panel of experts will discuss the implications of each and how to go about addressing them.

As you continue expanding digital pathology to drive research, overcoming these 5 obstacles is critical to creating an enterprise-wide digital ecosystem to drive more informed decision-making.

Presented at as a joint webinar with Proscia on March 4, 2021.

• • Struggle to collaborate with internal and external experts

• • Have data distributed across your organization, slowing down your work and siloing your analysis

• • Are looking to get more value from the data you have

Regan Baird, PhD, Scientific Consulting Sales Manager, Visiopharm

Regan has been with Visiopharm, Inc. since October 2015 and currently manages the eastern half of North America. Beginning with his Ph.D. at Temple University in Philadelphia and Post-Doctoral Fellowship at Beth Israel Deaconess Medical Center in Boston, he has spent over 20 years translating cellular and tissue based digital image analysis to biologists. Regan enjoys empowering pathologists with new digital tools to augment their workflow and enrich tissue-based analyses.

Ash Wilson, Product Manager, Research, Proscia

Ash Wilson is the Product Manager for Life Sciences at Proscia and has been in Life Sciences for over 15 years. She also has nearly a decade’s worth of field experience, including labs in digital pathology serial staining practices.